Detalliptinium

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameDetalliptinium
Drug Alias NameDTLDatelliptium chlorideSR-95156BNSC-311152
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTopoisomerase II inhibitors
TargetsTopoisomerase II
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCentre National De La Recherche Scientifique (Cnrs)Bpi-Groupe
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCentre National De La Recherche Scientifique (Cnrs)Bpi-GroupeSanofi
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A